Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sysmex Corporation ADR (SSMXY : OTC)
 
 • Company Description   
Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.

Number of Employees: 11,012

 
 • Price / Volume Information   
Yesterday's Closing Price: $16.65 Daily Weekly Monthly
20 Day Moving Average: 129,508 shares
Shares Outstanding: 629.48 (millions)
Market Capitalization: $10,480.82 (millions)
Beta: 1.14
52 Week High: $22.00
52 Week Low: $14.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -3.00%
12 Week -12.41% -24.08%
Year To Date -8.92% -13.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1-5-1 Wakihama Kaigan-dori Chuo-ku
-
Kobe,M0 651-0073
JPN
ph: 817-8265-0500
fax: 817-8265-0524
None http://www.sysmex.co.jp
 
 • General Corporate Information   
Officers
Tsune Ieji - Group Chief Executive Officer;Chairman and Directo
Kaoru Asano - President;Chief Executive Officer and Director
Tomokazu Yoshida - Chief Technology Officer and Director
Kazuo Ohta - Director
Haruo Inoue - Director

Peer Information
Sysmex Corporation ADR (ABMD)
Sysmex Corporation ADR (DMDS)
Sysmex Corporation ADR (CPWY.)
Sysmex Corporation ADR (EQUR)
Sysmex Corporation ADR (ECIA)
Sysmex Corporation ADR (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 87184P109
SIC: 8880
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 629.48
Most Recent Split Date: 4.00 (1.50:1)
Beta: 1.14
Market Capitalization: $10,480.82 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.96%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.16
Current Fiscal Year EPS Consensus Estimate: $0.64 Payout Ratio: 0.28
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 26.02
Trailing 12 Months: 29.73
PEG Ratio: -
Price Ratios
Price/Book: 3.42
Price/Cash Flow: 17.18
Price / Sales: 3.14
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -29.41%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 13.88%
ROE
06/30/25 - -
03/31/25 - 11.81
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - 8.38
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - 2.97
12/31/24 - 3.13
Quick Ratio
06/30/25 - -
03/31/25 - 2.30
12/31/24 - 2.33
Operating Margin
06/30/25 - -
03/31/25 - 10.56
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - 10.56
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - 15.57
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - 4.87
12/31/24 - 4.86
Inventory Turnover
06/30/25 - -
03/31/25 - 2.77
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.12
12/31/24 - 0.11
Debt-to-Capital
06/30/25 - -
03/31/25 - 10.67
12/31/24 - 9.87
 

Powered by Zacks Investment Research ©